Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 22 of 133 for:    "Paroxysmal Ventricular Fibrillation"

INSIGHTS ICD Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00279968
Recruitment Status : Completed
First Posted : January 20, 2006
Last Update Posted : December 28, 2007
Sponsor:
Collaborator:
Medtronic
Information provided by:
Medtronic Cardiac Rhythm and Heart Failure

Brief Summary:
The purpose of the Registry is to collect data on how Implantable Cardioverter Defibrillator (ICD) therapies and medications are being used by physicians to treat ventricular arrhythmias in order to better understand how to improve the clinical care of patients and effectiveness of ICD therapies.

Condition or disease Intervention/treatment
Ventricular Tachycardia Ventricular Fibrillation Device: ICD

Layout table for study information
Study Type : Observational
Enrollment : 1326 participants
Time Perspective: Prospective
Official Title: Investigating Significant ICD Heart Therapies Registry Study (INSIGHTS ICD Registry)
Study Start Date : February 2004
Study Completion Date : January 2006






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients 18 years of age or older.
  • Patients or legal guardians who are willing and able to sign a Permission for Access to and Use of Health Information in a Registry Form and, if required by an Institution's IRB, an Informed Consent.
  • New or replacement implants of Medtronic market released single, dual or triple chamber ICDs including: GEM VR, GEM DR, GEM III AT, Marquis VR, Marquis DR, Maximo DR, Maximo VR, InSync ICD, InSync Marquis ICD and InSync II Marquis ICD.

Exclusion Criteria:

  • Patients enrolled in a device study which effects programming and or treatment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00279968


  Hide Study Locations
Locations
Layout table for location information
United States, Arkansas
Little Rock, Arkansas, United States
United States, California
Fountain Valley, California, United States
Poway, California, United States
Sacramento, California, United States
Santa Ana, California, United States
United States, Colorado
Boulder, Colorado, United States
United States, Florida
Bradenton, Florida, United States
Lakeland, Florida, United States
Lauderdale Lakes, Florida, United States
Palm Beach Gardens, Florida, United States
Panama City, Florida, United States
Pembroke Pines, Florida, United States
Tampa, Florida, United States
United States, Georgia
Atlanta, Georgia, United States
Gainesville, Georgia, United States
United States, Illinois
Chicago, Illinois, United States
United States, Indiana
Crown Point, Indiana, United States
Noblesville, Indiana, United States
United States, Louisiana
Monroe, Louisiana, United States
United States, Maryland
Annapolis, Maryland, United States
Glen Burnie, Maryland, United States
United States, Massachusetts
Boston, Massachusetts, United States
United States, Michigan
Detroit, Michigan, United States
Kalamazoo, Michigan, United States
United States, Missouri
Columbia, Missouri, United States
United States, Nebraska
Omaha, Nebraska, United States
United States, New Jersey
Newark, New Jersey, United States
Pomona, New Jersey, United States
United States, New York
Brooklyn, New York, United States
Mineola, New York, United States
Williamsville, New York, United States
United States, North Carolina
Charlotte, North Carolina, United States
United States, North Dakota
Minot, North Dakota, United States
United States, Ohio
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Kettering, Ohio, United States
United States, Pennsylvania
Lancaster, Pennsylvania, United States
Langhorne, Pennsylvania, United States
United States, Rhode Island
Providence, Rhode Island, United States
United States, Texas
Austin, Texas, United States
Fort Worth, Texas, United States
Houston, Texas, United States
McAllen, Texas, United States
United States, Virginia
Fredericksburg, Virginia, United States
Sponsors and Collaborators
Medtronic Cardiac Rhythm and Heart Failure
Medtronic
Investigators
Layout table for investigator information
Principal Investigator: Alfred Buxton, MD Rhode Island Hospital

Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00279968     History of Changes
Other Study ID Numbers: 231
First Posted: January 20, 2006    Key Record Dates
Last Update Posted: December 28, 2007
Last Verified: December 2007

Keywords provided by Medtronic Cardiac Rhythm and Heart Failure:
ICD
Registry
Ventricular tachycardia
Ventricular Fibrillation

Additional relevant MeSH terms:
Layout table for MeSH terms
Tachycardia
Tachycardia, Ventricular
Ventricular Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Cardiac Conduction System Disease
Pathologic Processes